Most of us were so relieved when the first coronavirus vaccines made it to our shores last week. But a study has put something of a damper on that, as it shows the Oxford AstraZeneca shot is less effective against the variant of the virus dicovered in South Africa. Professor Tulio de Oliveira, director of the KwaZulu-Natal Research Innovation and Sequencing Platform, speaks on this. Courtesy #DStv403 JOHANNESBURG - The results of the AstraZeneca vaccine should be seen in a positive light according to Professor Tulio de Oliveira. According to the professor, South Africa is being respected internationally as one of the leading countries that can answer crucial questions around variants and vaccines. READ: J&J applies for emergency use of COVID-19 vaccine The vaccine has shown to be less effective against the COVID-19 variant first discovered in South Africa. With all the uncertainty around AstraZeneca’s COVID-19 shot in the country, Have our vaccine hope dwindled? Director of the Vaccines and Infectious Diseases Analytical Research Unit at WITS University Professor Shabir Madhi, weighs in. Courtesy #DStv403 While many have given the AstraZeneca vaccine a thumbs-down for use in SA, Wits vaccinology professor Shabir Madhi says all is not lost. "Anyone who says it is a waste of money does not understand the dynamics behind trying to secure vaccines," says Madhi. "If South Africa wants to wait for the results of a perfect vaccine, that means we'll be waiting around for 2023 and 2024 before we get any vaccine that becomes available," he says. Meanwhile, Johnson & Johnson has submitted applications for emergency use of its COVID-19 vaccine in SA. Watch the videos above for more details on this story.